TIRZEPATIDE 15MG VIAL – GENLABS

Tirzepatide 15mg Vial by Genlabs is a cutting-edge pharmaceutical product designed to support individuals in managing type 2 diabetes and obesity. This innovative medication combines the benefits of a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, offering a comprehensive approach to blood sugar regulation and weight management. Each vial contains 15mg of Tirzepatide, accompanied by bacteriostatic water for reconstitution, ensuring optimal efficacy and safety.

Key Features:

1. Dual-Action Mechanism:
   Tirzepatide works by simultaneously activating GIP and GLP-1 receptors, which play crucial roles in glucose metabolism and appetite regulation. This dual-action mechanism helps to:

   • Enhance insulin secretion in response to meals.

   • Suppress glucagon release, reducing blood sugar levels.

   • Slow gastric emptying, promoting a feeling of fullness and reducing caloric intake.

2. Effective Dosage:
   Each vial contains 15mg of Tirzepatide, providing a potent dose that can be tailored to individual patient needs. The inclusion of bacteriostatic water ensures that the medication remains sterile and effective for multiple uses.

3. Bacteriostatic Water:
   The accompanying bacteriostatic water contains 0.9% benzyl alcohol, which inhibits the growth of bacteria, making it safe for multiple-dose use. This ensures that the reconstituted solution remains stable and effective over time.

4. Clinical Efficacy:
   Clinical trials have demonstrated that Tirzepatide significantly reduces HbA1c levels and promotes substantial weight loss in patients with type 2 diabetes. Patients have reported improved glycemic control and a reduction in body weight, making it a valuable tool in diabetes and obesity management.

5. User-Friendly Administration:
   The vial is designed for easy reconstitution and administration. Healthcare providers can instruct patients on the proper technique for mixing and injecting the medication, ensuring a seamless experience.

6. High-Quality Manufacturing:
   Produced by Genlabs, a reputable pharmaceutical company known for its commitment to quality and innovation, Tirzepatide 15mg Vial is manufactured under strict regulatory standards. Each batch undergoes rigorous testing to ensure purity, potency, and safety.

Indications:

• Management of type 2 diabetes mellitus in adults.

• Adjunct to diet and exercise to improve glycemic control.

• Weight management in adults with obesity or overweight with at least one weight-related comorbidity.

Dosage and Administration:

• The recommended starting dose is 2.5mg once weekly, with gradual titration based on patient response and tolerability.

• The maximum recommended dose is 15mg once weekly.

• Administer subcutaneously in the abdomen, thigh, or upper arm.

• Rotate injection sites to reduce the risk of lipodystrophy.

Safety Information:

• Common side effects may include nausea, vomiting, diarrhea, decreased appetite, and constipation.

• Contraindicated in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.

• Use with caution in patients with a history of pancreatitis or severe gastrointestinal disease.

Storage:

• Store the unopened vial in a refrigerator at 2°C to 8°C (36°F to 46°F).

• Do not freeze.

• After reconstitution, store the solution in the refrigerator and use within a specified period as directed by the healthcare provider.

Conclusion:
Tirzepatide 15mg Vial (with Bacteriostatic Water) by Genlabs represents a significant advancement in the treatment of type 2 diabetes and obesity. Its dual-action mechanism, combined with high-quality manufacturing and user-friendly administration, makes it an essential option for patients seeking effective and reliable management of their condition. Consult your healthcare provider to determine if Tirzepatide is right for you.